Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 104001-104050 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05993299
Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Untreated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell Liposarcoma
PHASE2Active, not recruiting
7 participants
Started: Dec 31, 2019 · Completed: Jul 1, 2025
1 condition1 sponsor38 locations
NCT04098471
Simple Transanal Local Excision,Transanal Local Excision Following Radiotherapy Versus Total Mesorectum Excision for the Treatment of the Ultra-low T2N0M0 Rectal Cancer
NANot yet recruiting
300 participants
Started: Dec 31, 2019 · Completed: Dec 31, 2026
1 condition1 sponsor0 locations
NCT04209829
Response to Chimeric Antigen Receptor (CAR)-T Cells Therapy in Patients With Hematologic Malignancies Depending on Tumor Characteristics
N/ANot yet recruiting
600 participants
Started: Dec 31, 2019 · Completed: Mar 31, 2035
1 condition1 sponsor0 locations
NCT03991832
Study of Olaparib and Durvalumab in IDH-Mutated Solid Tumors
PHASE2Recruiting
58 participants
Started: Dec 31, 2019 · Completed: Mar 31, 2025
4 conditions1 sponsor1 location
NCT04167332
Prospective Collection of Samples for Urothelial Cancer of Bladder
N/ANot yet recruiting
630 participants
Started: Dec 31, 2019 · Completed: Dec 31, 2029
1 condition7 sponsors0 locations
NCT04165993
Study of KN026 Monotherapy or Combination Therapy in Patients With Metastatic Breast Cancer
PHASE2Active, not recruiting
68 participants
Started: Dec 31, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03967223
Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors
PHASE2Active, not recruiting
103 participants
Started: Dec 31, 2019 · Completed: Jul 31, 2026
1 condition1 sponsor38 locations
NCT04229459
Trial of Nivolumab and Cetuximab After Chemoradiation in Esophageal Squamous Cell Carcinoma Patients.
PHASE2Recruiting
31 participants
Started: Dec 30, 2019 · Completed: Jun 30, 2027
1 condition3 sponsors1 location
NCT04169152
CAES for Internal Hemorrhoids and Rectal Prolapse
N/ARecruiting
10,000 participants
Started: Dec 30, 2019 · Completed: Jun 30, 2028
2 conditions1 sponsor1 location
NCT03896503
Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs
PHASE2Active, not recruiting
104 participants
Started: Dec 30, 2019 · Completed: Jun 23, 2026
6 conditions1 sponsor33 locations
NCT03989206
Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis
PHASE3Active, not recruiting
1,700 participants
Started: Dec 30, 2019 · Completed: Aug 31, 2026
1 condition1 sponsor343 locations
NCT05740163
Oral Immunotherapy for Egg Allergy in Children Aged 6 to 16
NARecruiting
60 participants
Started: Dec 30, 2019 · Completed: Dec 31, 2026
1 condition3 sponsors2 locations
NCT06100367
11C-Metomidate PET/CT for Endocrine Hypertension and Characterisation of Adrenal Tumours
PHASE2/PHASE3Recruiting
100 participants
Started: Dec 30, 2019 · Completed: Jul 31, 2025
3 conditions8 sponsors7 locations
NCT04626882
Timing of FFR-guided PCI for Non-IRA in STEMI and MVD (OPTION-STEMI)
NAActive, not recruiting
994 participants
Started: Dec 30, 2019 · Completed: Dec 31, 2029
2 conditions1 sponsor14 locations
NCT04221503
Niraparib/TTFields in GBM
PHASE2Active, not recruiting
30 participants
Started: Dec 30, 2019 · Completed: Jan 31, 2026
3 conditions3 sponsors1 location
NCT04218968
Cardiac Changes in Early Parkinson's Disease: a Follow Up Study
PHASE2Enrolling by invitation
15 participants
Started: Dec 30, 2019 · Completed: Dec 30, 2025
3 conditions1 sponsor1 location
NCT04165317
A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer
PHASE3Active, not recruiting
1,070 participants
Started: Dec 30, 2019 · Completed: Dec 2, 2026
1 condition1 sponsor181 locations
NCT04215913
Integrative Analysis of Pulmonary Sarcomatoid Carcinoma (PSC)
N/ANot yet recruiting
300 participants
Started: Dec 30, 2019 · Completed: Dec 24, 2025
1 condition3 sponsors1 location
NCT04186325
Diaphragm Training Ultrasound
NARecruiting
70 participants
Started: Dec 28, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04222634
Metastasis-directed Therapy in Castration-refractory Prostate Cancer
NAActive, not recruiting
18 participants
Started: Dec 27, 2019 · Completed: Jan 1, 2030
1 condition1 sponsor1 location
NCT04216576
A Study of the Use of Text Message Reminders to Take Palbociclib
NAActive, not recruiting
45 participants
Started: Dec 27, 2019 · Completed: Dec 27, 2025
1 condition1 sponsor7 locations
NCT04212715
Prostate SABR With Intra-Prostatic SABR Boost
PHASE2Recruiting
30 participants
Started: Dec 26, 2019 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04365751
To Compare the Efficacy of Microwave Ablation and Laparoscopic Hepatectomy for Hepatocellular Carcinoma
NARecruiting
1,134 participants
Started: Dec 26, 2019 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04040569
A Phase I Dose Escalation Study of Single Fraction Pre-operative Partial Breast (S-PBI) for Early Stage Breast Cancer
PHASE1Active, not recruiting
45 participants
Started: Dec 25, 2019 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT06268132
Longevity in Russia
N/ARecruiting
4,000 participants
Started: Dec 25, 2019 · Completed: Dec 31, 2025
5 conditions2 sponsors1 location
NCT04212481
RCT of Uniport VATS for Lung Cancer
NARecruiting
300 participants
Started: Dec 25, 2019 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT04169997
A Study of IMP4297 as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer
PHASE3Active, not recruiting
404 participants
Started: Dec 24, 2019 · Completed: Jun 30, 2026
1 condition1 sponsor2 locations
NCT04212780
Dual Lead Thalamic Deep Brain Recording (DBR)-DBS Interface for Closed Loop Control of Severe Essential Tremor
NARecruiting
10 participants
Started: Dec 24, 2019 · Completed: Dec 31, 2029
1 condition3 sponsors1 location
NCT07040150
Evaluation of a Novel Semi-Rigid Brace for Adolescent Idiopathic Scoliosis
N/AActive, not recruiting
60 participants
Started: Dec 24, 2019 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT04343820
Delayed Breast Reconstruction by Prepectoral Implant After Lipo-preparation (RM2prepec)
N/AActive, not recruiting
60 participants
Started: Dec 24, 2019 · Completed: Dec 24, 2024
1 condition1 sponsor1 location
NCT04501913
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
N/AActive, not recruiting
22 participants
Started: Dec 24, 2019 · Completed: Nov 20, 2025
172 conditions2 sponsors1 location
NCT04990297
Cardiac Magnetic Resonance for Risk Stratification in Dilated Cardiomyopathy
N/ARecruiting
2,500 participants
Started: Dec 24, 2019 · Completed: Dec 31, 2031
2 conditions1 sponsor1 location
NCT04422249
A Study of Laparoscopic Middle Hepatic Vein Guidance and Traditional Anatomic Hemihepatectomy
NARecruiting
95 participants
Started: Dec 23, 2019 · Completed: Dec 23, 2023
1 condition1 sponsor1 location
NCT04155749
Study of Anitocabtagene-autoleucel in Participants With Relapsed Refractory Multiple Myeloma
PHASE1Active, not recruiting
40 participants
Started: Dec 23, 2019 · Completed: Jun 30, 2026
1 condition2 sponsors4 locations
NCT04150887
Cusatuzumab in Combination With Background Therapy for the Treatment of Participants With Acute Myeloid Leukemia
PHASE1Active, not recruiting
61 participants
Started: Dec 23, 2019 · Completed: May 15, 2026
1 condition3 sponsors23 locations
NCT04150939
Cryoablation for the Treatment of Metastatic Cancer
NAActive, not recruiting
15 participants
Started: Dec 23, 2019 · Completed: Aug 31, 2026
1 condition2 sponsors1 location
NCT04212013
A Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone Lymphoma
PHASE3Active, not recruiting
23 participants
Started: Dec 23, 2019 · Completed: Mar 18, 2027
1 condition2 sponsors10 locations
NCT04722822
The HPV 9-10 Trial: Early Initiation of HPV Vaccination
NARecruiting
3,100 participants
Started: Dec 23, 2019 · Completed: Apr 1, 2027
1 condition3 sponsors2 locations
NCT03967158
Evaluation of Effectiveness and Safety of XIENCE Sierra in Routine Clinical Practice
N/AActive, not recruiting
2,000 participants
Started: Dec 23, 2019 · Completed: Dec 31, 2028
2 conditions2 sponsors10 locations
NCT04118790
Microstructure Imaging in Stroke Patients
N/ARecruiting
90 participants
Started: Dec 23, 2019 · Completed: Mar 1, 2029
3 conditions2 sponsors2 locations
NCT04049604
IDENTIFY Study: Natural History of Maternal Neoplasia
N/ARecruiting
320 participants
Started: Dec 23, 2019 · Completed: Apr 30, 2029
1 condition1 sponsor1 location
NCT04225871
Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis
PHASE3Active, not recruiting
200 participants
Started: Dec 23, 2019 · Completed: Jun 2, 2026
1 condition1 sponsor70 locations
NCT04071951
Pharmacist Intervention to Reduce Post-Hospitalization Utilization
NAActive, not recruiting
6,478 participants
Started: Dec 23, 2019 · Completed: Sep 15, 2025
3 conditions2 sponsors2 locations
NCT04113395
Concordance and Accuracy of MRI in the Detection of Meningiomas: Optimizing Sequences With Low Doses of Gadolinium
N/ARecruiting
500 participants
Started: Dec 23, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor10 locations
NCT03917303
Control Crohn Safe Trial
PHASE4Recruiting
158 participants
Started: Dec 23, 2019 · Completed: Sep 30, 2026
2 conditions3 sponsors6 locations
NCT04093986
Hydroxyurea Exposure Limiting Pregnancy and Follow-Up Lactation
N/ARecruiting
200 participants
Started: Dec 22, 2019 · Completed: Dec 31, 2026
2 conditions6 sponsors1 location
NCT04878783
Radiomics and Molecular Expression Predictive Model for Esophago-Gastric Junction and Gastric Cancer TRG
N/AActive, not recruiting
138 participants
Started: Dec 20, 2019 · Completed: Oct 30, 2027
2 conditions2 sponsors5 locations
NCT04027309
A Study of Gilteritinib Versus Midostaurin in Combination With Induction and Consolidation Therapy Followed by One-year Maintenance in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndromes With Excess Blasts-2 With FLT3 Mutations Eligible for Intensive Chemotherapy
PHASE3Active, not recruiting
777 participants
Started: Dec 20, 2019 · Completed: Jun 30, 2033
2 conditions3 sponsors193 locations
NCT04574440
Functional Near Infrared Spectroscopy in Adult Surgery
N/ARecruiting
40 participants
Started: Dec 20, 2019 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT04356612
Barriers to Efficient PACU Discharge At a Major Academic Orthopaedic Ambulatory Surgery Center
N/AActive, not recruiting
1,000 participants
Started: Dec 20, 2019 · Completed: Nov 6, 2025
2 conditions1 sponsor1 location